**Core Concept**
Chronic amiodarone therapy can lead to various adverse effects due to its complex pharmacological profile, including its iodine content, lipophilicity, and interactions with multiple ion channels and receptors. Amiodarone is a Class III antiarrhythmic agent that can cause both cardiac and non-cardiac side effects.

**Why the Correct Answer is Right**
The correct answer is one of the options listed below. Each option will be explained in detail.

**Why Each Wrong Option is Incorrect**
To determine the correct answer, let's evaluate each option:

* **Option A:** Thyroid dysfunction is a well-known adverse effect of chronic amiodarone therapy. Amiodarone contains 37% iodine by weight, which can lead to hypothyroidism or hyperthyroidism in susceptible individuals. Therefore, this is an adverse effect of amiodarone therapy.
* **Option B:** Corneal deposits are a common adverse effect of chronic amiodarone therapy. Amiodarone can cause the deposition of lipofuscin in the corneal epithelium, leading to visual disturbances and changes in corneal appearance. Thus, this is an adverse effect of amiodarone therapy.
* **Option C:** Hepatotoxicity is a rare but serious adverse effect of chronic amiodarone therapy. Amiodarone can cause liver damage, including hepatitis and cirrhosis, in some patients. Therefore, this is an adverse effect of amiodarone therapy.
* **Option D:** Amiodarone therapy is not commonly associated with an increased risk of **myocardial infarction**. While amiodarone can cause cardiac side effects, such as QT interval prolongation and cardiac conduction abnormalities, it is not typically associated with an increased risk of myocardial infarction.

**Clinical Pearl / High-Yield Fact**
When prescribing amiodarone, it is essential to monitor patients for signs of thyroid dysfunction, corneal deposits, and hepatotoxicity. Patients should also be advised to report any visual changes or symptoms of thyroid dysfunction promptly.

**Correct Answer: D. Amiodarone therapy is not commonly associated with an increased risk of myocardial infarction.**